AKT1 and neoplasm: Downregulation of phospho‐AKT and phospho‐ERK within 6 h of HSB‐510 treatment confirmed the inhibitory effect on PI3‐K signaling pathways, which is the most frequently activated intracellular pathway that contributes to tumor progression.